|
Volumn 357, Issue 9267, 2001, Pages 1533-1534
|
Sexually transmitted diseases in HIV-1-infected patients
a a
a
G3 7NB
*
(United Kingdom)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
COTRIMOXAZOLE;
SILDENAFIL;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANALYTIC METHOD;
CHLAMYDIASIS;
DISEASE TRANSMISSION;
GONORRHEA;
HERPES;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 2;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
LYMPHOCYTE COUNT;
PATIENT;
PNEUMONIA;
PRIORITY JOURNAL;
PROPHYLAXIS;
RISK;
SEX;
SEXUAL BEHAVIOR;
SEXUAL DYSFUNCTION;
SEXUALLY TRANSMITTED DISEASE;
SYPHILIS;
URETHRITIS;
VIRUS DETECTION;
VIRUS LOAD;
WELLBEING;
ADULT;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MALE;
NOTE;
RISK ASSESSMENT;
UNITED KINGDOM;
AIDS RELATED COMPLEX;
LONG TERM CARE;
PNEUMOCYSTIS PNEUMONIA;
RISK FACTOR;
ADULT;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
ENGLAND;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
RISK ASSESSMENT;
SEXUALLY TRANSMITTED DISEASES;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
LONG-TERM CARE;
PNEUMONIA, PNEUMOCYSTIS;
RISK FACTORS;
SEXUALLY TRANSMITTED DISEASES, BACTERIAL;
TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;
|
EID: 0035849366
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/s0140-6736(00)04692-4 Document Type: Letter |
Times cited : (4)
|
References (5)
|